Dupilumab significantly improves itch and skin lesions in patients with prurigo nodularis: Pooled results from two phase 3 trials (liberty-pn prime and prime2)

被引：0
|
作者：
Yosipovitch, G. [7 ]
Kwatra, S. G. [9 ]
Mollanazar, N. [1 ]
Staender, S. [2 ]
Satoh, T. [3 ]
Laws, E. [4 ]
Mannent, L. P. [5 ]
Mortensen, E. [6 ]
Maloney, J. [6 ]
Shi, G. [4 ]
Bansal, A. [6 ]
Martincova, R. [8 ]
机构：
[1] Univ Penn, Philadelphia, PA USA
[2] Univ Hosp Munster, Munster, Germany
[3] Natl Def Med Coll, Tokorozawa, Saitama, Japan
[4] Sanofi, Bridgewater, NJ USA
[5] Sanofi, Chilly Mazarin, France
[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[7] Univ Miami, Miami, FL USA
[8] Sanofi, Prague, Czech Republic
[9] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
650
引用
收藏
页码：S111 / S111
页数：1
相关论文
共 33 条
  • [1] Dupilumab significantly improves itch and skin lesions in patients with prurigo nodularis: pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)
    Yosipovitch, Gil
    Kwatra, Shawn G.
    Mollanazar, Nicholas
    Staender, Sonja
    Satoh, Takahiro
    Laws, Elizabeth
    Mannent, Leda P.
    Mortensen, Eric
    Maloney, Jennifer
    Shi, Genming
    Bansal, Ashish
    Martincova, Renata
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [2] Dupilumab improves pruritus and skin lesions in patients with prurigo nodularis: Pooled results from 2 phase 3 trials (LIBERTY-PN PRIME and PRIME2)
    Yosipovitch, Gil
    Kim, Brian S.
    Kwatra, Shawn G.
    Mollanazar, Nicholas K.
    Stander, Sonja
    Satoh, Takahiro
    Mendes-Bastos, Pedro
    Tsai, Tsen-Fang
    Laws, Elizabeth
    Nivens, Michael C.
    Maloney, Jennifer
    Shi, Genming
    Bansal, Ashish
    Dubost-Brama, Ariane
    JAAD INTERNATIONAL, 2024, 16 : 163 - 174
  • [3] Dupilumab improves itch and skin lesions in North American patients with prurigo nodularis: a subset analysis of the pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)
    Elmariah, Sarina B.
    Mollanazar, Nicholas
    Hong, H. Chi-ho
    Walker, Kirsten
    Butler, Daniel C.
    Praestgaard, Amy
    Zahn, Joseph
    Wiggins, Simmi
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [4] Dupilumab is efficacious in patients with prurigo nodularis regardless of baseline lesion severity: pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)
    Staender, Sonja
    Misery, Laurent
    Yosipovitch, Gil
    Park, Chang Ook
    Li, Lin-Feng
    Praestgaard, Amy
    Zahn, Joseph
    Wiggins, Simmi
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 18 - 19
  • [5] Dupilumab is efficacious in patients with prurigo nodularis regardless of history of atopic comorbidities: pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)
    Kim, Brian S.
    Goncalo, Margarida
    Ugajin, Tsukasa
    Praestgaard, Amy
    Makhija, Melanie
    Zahn, Joseph
    Bansal, Ashish
    Wiggins, Simmi
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II11 - II12
  • [6] Dupilumab reduces the number of lesions in adult patients with prurigo nodularis presenting with multiple lesion morphologies: pooled results from two phase 3 trials (LIBERTY-PN PRIME and PRIME2)
    Stander, Sonja
    Yosipovitch, Gil
    Kim, Brian S.
    Hong, H. Chih-ho
    Metz, Martin
    Murota, Hiroyuki
    Gao, Xing-Hua
    de Bruin-Weller, Marjolein
    Praestgaard, Amy
    Zahn, Joseph
    Wiggins, Simmi
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 93 - 94
  • [7] Dupilumab is efficacious in patients above and below 60 years old with prurigo nodularis: pooled results from two phase III trials (LIBERTY-PN PRIME and PRIME2)
    Kwatra, Shawn G.
    Staender, Sonja
    Bewley, Anthony
    Tsai, Tsen-Fang
    Fujita, Hideki
    Praestgaard, Amy
    Zahn, Joseph
    Wiggins, Simmi
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : I54 - I54
  • [8] Dupilumab Improves Itch, Skin Pain, and Sleep in Adult Patients With Prurigo Nodularis (LIBERTY PN-PRIME and PRIME2)
    Kwatra, Shawn G.
    Yosipovitch, Gil
    Staender, Sonja
    Guillemin, Isabelle
    Msihid, Jerome
    Wiggins, Simmi
    Levit, Noah A.
    Bansal, Ashish
    O'Malley, John T.
    Bahloul, Donia
    Thomas, Ryan B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB40 - AB40
  • [9] Dupilumab Improves Disease-Specific Quality of Life in Patients With Prurigo Nodularis (LIBERTY-PN PRIME and PRIME2)
    Kwatra, Shawn
    Yosipovitch, Gil
    Mollanazar, Nicolas
    Stander, Sonja
    Kim, Brian S.
    Msihid, Jerome
    Bansal, Ashish
    O'Malley, John T.
    Bahloul, Donia
    Thomas, Ryan B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB39 - AB39
  • [10] Dupilumab Improves Itch, Skin Pain, and Sleep in Adult PatientsWith Prurigo Nodularis (LIBERTY PN-PRIME and PRIME2)
    Kwatra, Shawn G.
    Yosipovitch, Gil
    Staender, Sonja
    Guillemin, Isabelle
    Msihid, Jerome
    Wiggins, Simmi
    Levit, Noah A.
    Bansal, Ashish
    O'Malley, John T.
    Bahloul, Donia
    Thomas, Ryan B.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 99 - 100
1234